Registering a CAGR of 14.2% over the forecast period, the market value of Transcatheter Aortic Valve Replacement is expected to reach US$ 9,240.4 million in the year 2027.
Transcatheter Aortic Valve Replacement (TAVR), also known as Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive surgery performed to insert a new valve without removing the damaged one. The narrowed aortic valve, which has failed to open properly (aortic valve stenosis), is replaced by a new one. The Transcatheter Aortic Valve Replacement market is driven by the increased incidence of cardiovascular diseases and the increasing geriatric population. There has been a higher acceptance in adopting advanced surgical procedures that have led to an increase in the investments and funding in health care by both government and individuals. There is also an availability of financial assistance for patients getting TAVR to lower the cost burden.
Technological advancements in surgical procedures are increasing the demand for transcatheter heart valves. Furthermore, a favorable reimbursement scenario and increased manufacturer interest are driving up transcatheter heart valve sales. Increased product development initiatives by companies are driving the most recent trends in the global transcatheter heart valve replacement market, resulting in increased transcatheter heart valve replacement market share.
The rise in incidences of valvular heart diseases across the globe along with increasing demand for less invasive procedures is propelling the industry growth. The growing geriatric population suffering from heart valve diseases is leading to an increase in valve replacement surgeries. Moreover, increasing technological advancements in surgical procedures are augmenting the transcatheter heart valve replacement market demand. Furthermore, the favorable reimbursement scenario and growing interest of manufacturers is fostering the market revenue.
The report aspects discussed the profile of the top manufacturers of the global Transcatheter Aortic Valve Replacement market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. The growth of the report has examined Transcatheter Aortic Valve Replacement Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
The global Transcatheter Aortic Valve Replacement includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Edwards Lifesciences Corporation (NYSE: EW), Medtronic Inc. (NYSE: MDT), Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), St. Jude Medical Inc., JenaValve Technology, SYMETIS, Braile Biomedica, CryoLife Inc., Micro Interventional Devices Inc., LivaNova Plc (NASDAQ: LIVN) and others.
April 8, 2021 — Abbott (NYSE: ABT) announced that its next-generation TriClipTM Transcatheter Tricuspid Valve Repair System has received CE Mark, making it the first-of-its-kind minimally invasive tricuspid heart valve repair device available in Europe to treat tricuspid regurgitation (TR). TriClip G4 is a non-surgical heart valve repair option specifically designed for the treatment of TR, or a leaky tricuspid valve, that allows physicians to tailor valve repair to each patient's unique anatomy.
Aug. 24, 2021 — Medtronic plc (NYSE: MDT), the global leader in medical technology, announced FDA approval of the EvolutTM FX TAVR system, its next-generation self-expanding transcatheter aortic valve replacement (TAVR) system. The Evolut FX system, designed to improve ease of use and provide greater precision and control throughout the procedure, maintains the Evolut platform's industry-leading hemodynamic (blood flow) and durability benefits while bringing product and procedure innovation to patients with symptomatic severe aortic stenosis.
April 23, 2019 --Boston Scientific Corporation (NYSE: BSX) announced that the LOTUS EdgeTM Aortic Valve System has been approved by the United States Food and Drug Administration (FDA). This transcatheter aortic valve replacement (TAVR) technology, which is delivered through a minimally invasive procedure, is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open-heart surgery.
The market is segmented based on the type, applications, companies, and regions.
By Type, it is segmented into
By Application, it is segmented into
North America currently dominates the global market for transcatheter aortic valve replacement and is expected to grow at a moderate rate over the forecast period. The introduction of technologically advanced and innovative products into the market would be primarily responsible for the market's growth in North America. Europe accounted for the second-largest share of the total transcatheter aortic valve replacement market. Factors such as an increase in the number of patients diagnosed with endovascular diseases, an increase in the number of endovascular procedures, and the introduction of novel products such as drug-coated balloons, chronic total occlusion devices, and aortic stents would increase demand for transcatheter aortic valve replacement in the European market.
The Transcatheter Aortic Valve Replacement Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Transcatheter Aortic Valve Replacement Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Scope of the Report covers the Transcatheter Aortic Valve Replacement Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Transcatheter Aortic Valve Replacement Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.
Report Attributes | Report Details |
Report Title | Transcatheter Aortic Valve Replacement Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Edwards Lifesciences Corporation (NYSE: EW), Medtronic Inc. (NYSE: MDT), LivaNova Plc (NASDAQ: LIVN) |
Forecast Period 2022 to 2027 CAGR | CAGR of 14.2% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Edwards Lifesciences Corporation, Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical, Inc., JenaValve Technology, SYMETIS, Braile Biomedica, CryoLife, Inc., Micro Interventional Devices, Inc., LivaNova Plc |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 117 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Transcatheter Aortic Valve Replacement Market is studied from 2017 - 2027.
What is the growth rate of the Transcatheter Aortic Valve Replacement Market?
The Transcatheter Aortic Valve Replacement Market is growing at a CAGR of 14.2% over the next 5 years.
Who are the key players in Transcatheter Aortic Valve Replacement Market?
Edwards Lifesciences Corporation, Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical, Inc., JenaValve Technology, SYMETIS, Braile Biomedica, CryoLife, Inc., Micro Interventional Devices, Inc., LivaNova Plc
What regions does this Transcatheter Aortic Valve Replacement Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Transcatheter Aortic Valve Replacement Market?
Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement, Transcatheter Pulmonary Valve Replacement
What are the major end-use applications of Transcatheter Aortic Valve Replacement Market?
Aortic Valvular Heart Disease, Mitral Valvular Heart Disease, Pulmonary Valvular Heart Disease
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.